Hydroxychloroquine as an add-on therapy for the induction therapy of MPO-AAV: a retrospective observational cohort study.

Yizi GongTing MengWei LinXueling HuRong TangQi XiongJoshua D OoiPeter J EggenhuizenJinbiao ChenYa-Ou ZhouHui LuoJia XuNing LiuPing XiaoXiangcheng XiaoYong Zhong

Published in: Clinical kidney journal (2024)

HCQ together with standard induction treatment may improve the remission rate of MPO-AAV patients, and HCQ had good safety in our study.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
gene therapy
peritoneal dialysis
patient reported outcomes
systemic lupus erythematosus
combination therapy
replacement therapy